RegeneRx Biopharmaceuticals, Inc.
RGRX
$0.0002
$0.000.00%
OTC PK
03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 101.60K | 290.90K | 478.40K | 706.60K | 925.30K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 21.70K | 10.00K | 21.00K | 19.00K | 13.30K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 6.00K | -- | -- | -- |
Total Current Assets | 123.30K | 306.90K | 499.40K | 725.60K | 938.60K |
|
|||||
Total Current Assets | 123.30K | 306.90K | 499.40K | 725.60K | 938.60K |
Net Property, Plant & Equipment | 57.80K | 69.50K | 75.80K | 4.20K | 16.20K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 5.80K | 5.80K | 5.80K | 5.80K | 5.80K |
Total Assets | 186.80K | 382.20K | 581.00K | 735.50K | 960.50K |
|
|||||
Total Accounts Payable | 38.70K | 63.80K | 37.20K | 45.40K | 31.70K |
Total Accrued Expenses | 469.30K | 369.70K | 329.10K | 306.50K | 278.30K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.21M | 43.40K | 33.20K | 4.20K | 16.30K |
Total Finance Division Other Current Liabilities | 76.80K | 76.80K | 76.80K | 76.80K | 76.80K |
Total Other Current Liabilities | 76.80K | 76.80K | 76.80K | 76.80K | 76.80K |
Total Current Liabilities | 1.80M | 553.70K | 476.20K | 432.90K | 403.00K |
|
|||||
Total Current Liabilities | 1.80M | 553.70K | 476.20K | 432.90K | 403.00K |
Long-Term Debt | 262.00K | 1.37M | 1.31M | 1.25M | 1.20M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 17.70K | 30.20K | 42.10K | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.85M | 1.87M | 1.89M | 1.91M | 1.93M |
Total Liabilities | 3.93M | 3.83M | 3.72M | 3.60M | 3.53M |
|
|||||
Common Stock & APIC | 108.86M | 108.77M | 108.69M | 108.60M | 108.35M |
Retained Earnings | -112.60M | -112.22M | -111.83M | -111.46M | -110.91M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -3.74M | -3.45M | -3.14M | -2.86M | -2.57M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -3.74M | -3.45M | -3.14M | -2.86M | -2.57M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -3.74M | -3.45M | -3.14M | -2.86M | -2.57M |
|